Coherence is developing brain-computer interface (BCI) technology for cancer care. Its goal is to track electrical signals associated with tumors and use that information to guide electrical stimulation, potentially allowing treatment to adapt as a tumor changes.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
10/26/26	$45,000,000	Series A	8VC Ahren Innovation Capital Artesian Blackbird Ventures Divergent Capital Founders Fund Lux Capital Olive Capital OpenAI Startup Fund Possible Ventures Timeless Partners Topology Ventures XEIA Venture Partners Xtal	undisclosed